Tuesday, 31 May 2011

SUGAR IN MARKET

Latest Update News About350,000 tons of sugar to off-load in market. The federal government has directed Trading Corporation of Pakistan to off-load 350,000 tonsof sugar stock to the market to end the artificial crisis.
According to a spokesperson of federal government, crushing has been started in Sindh’s sugar mills; where as the sugar mills in other parts of the country have been asked to immediately start crushing so that local sugar is available in the market within a month. The government has decided to off-load 350,000 tons of sugar to ensure smooth and ready accessibility of the commodity to the consumers. In accordance with the arrangement agreed upon by all the provincial governments, TCP will release 50% of its sugar stock to Punjab and remaining portion to other provinces on proportional basis at Rs. 56 per kilogram. The spokesman also told that after the release of sugar from the stocks by the Federal Government, supply of sugar to the consumers will become the responsibility of provincial governments.
Posted by at No comments:

ISF


Lahore:  The Pakistan government informed a court on Monday that it could not defend Jamaat-ud-Dawah chief Hafiz Muhammad Saeed in a US lawsuit filed by relatives of two Jewish victims of the 2008 Mumbai terror attacks.

Deputy Attorney General Naseem Kashmiri, in a written reply submitted on behalf of Foreign Ministry to Justice Umar Ata Bandial of the Lahore High Court, said: "The government is defending the ISI before the US court being an institute of the government while the JuD or its chief are not part of the government."

"Therefore, the government cannot provide legal assistance to him or his organisation," the reply said.

After examining the government's response, the judge asked Saeed's counsel A K Dogar to present the law under which the court could direct the government to defend a private individual in a US court.

  • NDTV

Dogar sought time to prepare his arguments and the court adjourned the matter till June 30.

The lawsuit was filed in a Brooklyn court last year by relatives of US nationals Rabbi Gabriel Noah Holtzberg and his wife Rivka, who were among the 166 people killed in the Mumbai attacks.

The US court had issued summons to Saeed, the current and a former head of the Inter-Services Intelligence agency and several other persons who were named in the lawsuit.

The lawsuit accuses Lashkar-e-Taiba leader Hafiz Saeed, commanders Zakiur Rehman Lakhvi, Azam Cheema and Sajid Majid, former ISI chief Nadeem Taj, incumbent head Lt Gen Ahmed Shuja Pasha and two others of providing material support for the Mumbai attacks.

For each of nine claims, the plaintiffs have sought damages of USD 75,000.

Saeed contended that he is the head of the JuD and had no links with LeT.

He contended that the government should defend him in the lawsuit in the same manner that it is protecting the ISI chief and other officials. 
Posted by at No comments:

Thursday, 26 May 2011

akon new love song


Posted by at No comments:

cure for aids????



philanthropic, giving, donations, donate please


Has BYU prof found AIDS cure?

Compound could be long-sought breakthrough

By Bob Mims
The Salt Lake Tribune

Researchers, including a BYU scientist, believe they have found a new compound that could finally kill the HIV/AIDS virus, not just slow it down as current treatments do.
   And, unlike the expensive, drug cocktails 25 years of research have produced for those with the deadly virus, the compound invented by Paul D. Savage of Brigham Young University appears to hunt down and kill HIV.
    Although so far limited to early test tube studies, CSA-54, one of a family of compounds called Ceragenins (or CSAs), mimics the disease-fighting characteristics of anti-microbial and anti-viral agents produced naturally by a healthy human immune system.
    Under a study sponsored by Ceragenix Pharmaceuticals, Savage and his colleagues developed and synthesized the compound for Vanderbilt University's School of Medicine. In his Nashville, Tenn., laboratories, Derya Unutmaz, an associate professor of Microbiology and Immunology, tested several CSAs for their ability to kill HIV.
    While issuing a cautious caveat about his early results, Unutmaz acknowledged Monday that CSAs could be the breakthrough HIV/AIDS researchers have sought for so long.
    "We received these agents [from BYU] in early October and our initial results began to culminate by November 2005. We have since reproduced all our results many times," he said. "We have some preliminary but very exciting results [but] we would like to formally show this before making any claims that would cause unwanted hype."
    What studies to date show is a compound that attacks HIV at its molecular membrane level, disrupting the virus from interacting with their primary targets, the "T-helper" class white blood cells that comprise and direct the human immune system. Further, CSAs appear to be deadly to all known strains of HIV.
    That would be a welcome development for the estimated 40.3 million people now living with HIV/AIDS globally, including nearly 5 million newly infected in the past year alone.
    "We have devoted considerable resources to understand the mechanism of these compounds. We think this knowledge will enable us in collaboration with Dr. Savage to design even better compounds," Unutmaz said.
    In addition to being a potential checkmate to HIV, the compounds show indications of being just as effective against other diseases plaguing humankind - among them influenza, possibly even the dread bird flu, along with smallpox and herpes.
    Savage said he and his BYU research team had been studying CSAs for eight years, noting the compounds' value against microbial and bacteria infections. It was only a year ago they saw that CSAs killed viruses, too.
    "They kill viruses very effectively and in a way paralleling our own, natural defenses," Savage said, noting that beyond the obvious use as a weapon against the AIDS pandemic, CSAs could help many others with non-HIV immune deficiencies.
    Further, the compounds appear to have few limits on how they are delivered to patients. Although early indications are for application of CSAs with an ointment or cream, pills or injections may also be developed - if the compound gets to market.
    BYU and Vanderbilt have jointly filed a patent on CSA technology, which has been licensed exclusively to Ceragenix.
    Ceragenix CEO and Chairman Steven Porter said only further research will tell, but he was optimistic about the application of CSAs in the war on HIV/AIDS. There are indications that it could help battle antibiotic- and antiviral-resistance strains of disease as they manifest themselves.
    "We are encouraged . . . that CSAs may provide a completely unique family of anti-infectives, potentially active against a wide range of viral, fungal and bacterial targets, including those resistant to current therapies," he said.
    Assuming continued positive test results in animal and eventual human trials, Porter estimates it could be three to seven years before the compound is available by prescription. That transition could be accelerated, however, if the Food and Drug Administration should decide to fast-track the drug.
    That day is still a long way off, though. First, researchers plan to publish their results in scientific journals, seeking peer review and independent confirmation of their findings. Assuming no flaws are found, several rounds of testing would follow.
    Most of the nation's leading AIDS experts were attending the Conference on Retroviruses and Opportunistic Infections in Denver on Monday. The event's policies prohibits on-site news conferences or releases during the conference, and efforts to reach scientists there were not successful.
    Of the few AIDS research luminaries reached, all said they preferred not to comment on the Vanderbilt tests until full results are published.
    bmims@sltrib.com 
Posted by at No comments:

treatment for diabetes


New Treatment For Diabetes
What is New That
Makes Cure Possible

Dr. M. Sathiamurthi


Root Cause Therapy


You know Diabetes resists cure! You can not cure it until you get a new treatment which knows its causes.
Medical research has not yet found its exact causes. But now you have real good news from bioenergetics.
Bioenergetics has come out with anew diagnosis and a new treatmentfor diabetes and all other diseases.




The New Treatment


The inadequacy of allopathic methods is proved by diabetics suffering pre mature death due to heart disease, hyper tension, and strokes. They also suffer kidney disease, neuropathy, foot pain, retinopathy and impotence.

At last you have a new treatment for diabetes that takes you closer to a cure. The new treatment proves successful when combined with allopathic methods. See 41 New Methods Of Cures Assured By The New Treatment!

Radio Communications


It may surprise you! The new treatment makes radio communication with the human intelligence! It scans your energy fields and finds out the root causes! It also finds out your healing frequencies by hi-tech instruments!
You know it as the new diagnosis or E Diagnosis. It is followed by the New Treatment For Diabetes. This scientific e treatment or energy treatmentcures by restoring those healing frequencies into your body energy fields!







Removes Blockages


The new treatment for diabetes removes the energy flow blockages in your energy meridians and energy channels with in your body. It removes blockages in the lymphatic circuits and nerve signal communications.

Augments Allopathy


You will find that this New Treatment for Diabetes is a reinforcement to the allopathic procedures in treating diabetes. When you combine both the treatments, you get better results and better chances of a natural cure!

100% Non Invasive


You do not take any medicines or injections in your new diagnosis and new treatment. We do not use electricity or magnetism! We do not use any radiations at all. Your new treatment is one hundred percent non invasive.

No Side Effects


There are absolutely no side effects in the new treatment for diabetes. On the contrary, it removes all side effects caused by insulin injections and other medicines used in your regular treatments from your diabetes doctor.

Compatible To All


Your new treatment for diabetes is the latest method giving best results for all types of diabetes. It is compatible with all medical systems. It alone finds out the root causes which are not diagnosed by allopathic diagnosis.
It is an added plus in the new e treatment that it rectifies your root causedisorders in your DNA and heredity effectively. It achieves this by using special techniques from advanced quantum physics and bioenergetics.

Better Option


E Diagnosis and E Treatment examine your brain, endocrines, vital organs, nervous systems, time lags, blockages, and correct all disorders to heal you. Besides allopathy, this offers the best treatment option for diabetics.

Scientific Reports


Allopathic care may help, but that alone is not enough. Diabetes leaves you susceptible for many complications. This is why you must ensure your additional safety by taking e diagnosis and e treatment.
You now have detailed reports on Remote Diagnosis on a diabetes type 2 client. Each report is different with new scientific procedures. Click here to See Reports! See The World Of Difference From Allopathic Diagnosis!

What is Energy Treatment?

41 New Methods Of Cures In The New Treatment!
See Main Page For New Treatment for Diabetes! For More Details
The Striking Difference In This New Treatment For Diabetes!

Experiences With Any New
Treatment For Diabetes

Make your web page here. Tell us your experience of any new treatment for diabetes. We will publish your page helping many others who visit this site. To save your privacy, we shall keep your real name and emails confidential.

Here you can comment on this page, this site, on our diagnosis and on the new treatment for diabetes. Kindly avoid spelling mistakes, writing short cuts, i, u, ur, im, etc. and make it worthy of you and easy for us to
Posted by at No comments:

new games


Posted by at No comments:
Subscribe to: Posts (Atom)